NPAT swung to NZ$10.2m on NZ$12.4m portfolio total return

That carried PBT to NZ$10.6m (+200.0%) and NPAT to NZ$10.2m (+188.1%). Portfolio total return of 6.6% beat the 5.6% benchmark by 1.0pp, reversing the -12.8pp underperformance in the prior comparable. NTA per share recovered to $0.94 from $0.80 (still within the company's historical range of $0.80-$1.26x). Net assets reached NZ$201.6m, within the historical range. The interim dividend was lifted to 1.86 cps from 1.66 cps (+12%).

• Of the NZ$12.4m total return, dividend, interest and other income was just NZ$0.4m – within the historical range (mean NZ$0.5m). The remainder is fair-value movement on the portfolio. This matters because NPAT and ROE move with international equity markets, not with a stable income stream.

• Distribution coverage by running income remains thin. Investment income covered only 7.9% of distributions paid in the period. The vehicle continues to fund distributions primarily from realised gains and capital, which is structural for a listed investment company but means distribution capacity is dependent on portfolio performance rather than recurring yield.

• Benchmark-relative outperformance returned, against a weak benchmark. The 1.0pp excess return reverses last year's -12.8pp gap, but the 5.6% benchmark itself sits at the lower edge of the company's historical range (mean 8.8%). The win came against a low bar, not against a strong market.

The supplied historical baseline frames this result as exceptional rather than typical: investment total return at NZ$12.4m sits at the top of the 4-period range, and portfolio total return of 6.6% versus a 0.4% historical mean is similarly outsized. The release does not support an expectation that this run-rate repeats; it supports a read that HY23's loss has been recovered and NTA per share has rebuilt to $0.94, still 6 cents below the historical mean of $1.00.

The NZ$11.9m profit on investments disclosed in the release dwarfs running income of NZ$0.4m, so ROE of 5.1% (above the historical range, vs -7.1% prior) should be read as a portfolio-return measure, not an operating-return measure. Capital-gains-driven NPAT is normal for this vehicle, but it is volatile by definition – the same line was -NZ$9.4m a year ago.

The effective tax rate of 3.9% (vs -9.1% prior) is low because fair-value gains on the portfolio are largely not currently taxable until realised; this is structural to the investment-company vehicle, not a one-off benefit. The payout ratio versus NPAT fell to 38.1%, below the historical range of 55.1%-132.5% (mean 84.3%), but this is an arithmetic consequence of the inflated NPAT denominator rather than a deliberate retention policy, given the per-share distribution actually rose.

This briefing cannot assess the realised-versus-unrealised split of portfolio gains, the current management expense ratio, or where the listed share price sits relative to the disclosed NAV per share.